Advances in elderly chronic heart failure patients complicated with sarcopenia
10.3760/cma.j.cn114798-20210801-00583
- VernacularTitle:老年慢性心力衰竭合并肌少症的研究进展
- Author:
Luyao MA
1
;
Ping LIN
;
Qin WANG
;
Kanglu GAO
Author Information
1. 浙江中医药大学附属杭州第三医院老年科,杭州310009
- Keywords:
Heart failure;
Sarcopenia;
Elderly;
Pathogenesis;
Treatment
- From:
Chinese Journal of General Practitioners
2022;21(2):193-197
- CountryChina
- Language:Chinese
-
Abstract:
Chronic heart failure(CHF) is the end stage of various cardiovascular diseases and is one of the common diseases among the elderly in China. Sarcopenia is a geriatric syndrome characterized by the age-related loss of skeletal muscle quantity and/or mass and the decline in muscle strength and/or physical performance. There is a common pathophysiological mechanism of CHF and sarcopenia, and they interact with each other and influence each other′s prognosis. There are few confirmed effective treatments for sarcopenia, and even fewer measures that can help slow the progression of both syndromes. However, on the basis of heart failure treatment hormone therapy, exercise training and nutritional support may slow the progression of sacopenia. This article reviews the recent advances in the relationship between elderly CHF patients with sarcopenia and related treatment.